NCT05259696 Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) Status COMPLETED Phase PHASE1/PHASE2
NCT05239000 A Study Comparing Geriatric Co-Management With Geriatric Guided Supportive Care in Older Patients Receiving Chemoradiation Therapy for Their Head and Neck Cancer Status COMPLETED Phase NA
NCT05226871 Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05226065 The Relationship Between Intake of Macro and Micronutrients With Clinical Outcomes of Head and Neck Cancer Patients Status COMPLETED Phase N/A
NCT05207098 A Study of Neurocognitive Tests and Questionnaires for People With Head and Neck Cancer Who Are Undergoing Radiation Therapy Status RECRUITING Phase N/A
NCT05200650 A Single Arm, Prospective, Open Label, Multi Center, Phase Ib Study to Evaluate the Safety, Tolerability and Initial Efficacy of a Single Intra-tumoral Injection of IntraGel's Polymer-based Cisplatin-loaded Gel (TumoCure) in Subjects With Progressive or Radio-resistant Primary Head and Neck Tumor Status RECRUITING Phase PHASE1
NCT05187338 Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05184790 LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology Status RECRUITING Phase N/A
NCT05182866 ASP-1929 Photoimmunotherapy (PIT) Study in Patients With Recurrent Head/Neck Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05182229 Comparing Two Ways to Manage Head and Neck Lymphedema Status ACTIVE_NOT_RECRUITING Phase NA
NCT05180851 Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study Status UNKNOWN Phase EARLY_PHASE1
NCT05176834 Photobiomodulation Home-use Device for Prevention or Treatment of Oral Mucositis in Patients With Head&Neck Malignancies Status UNKNOWN Phase NA
NCT05170087 Radiomic Analysis for Predicting Treatment Response and Clinical Outcomes in Malignancies Status UNKNOWN Phase N/A
NCT05169437 Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors Status TERMINATED Phase PHASE2
NCT05160714 Individualized Response-adaptive Radiation Dose Prescription in HNC Based on MRI Status UNKNOWN Phase PHASE1